Prognostic Factors for Cirrhosis Hospital in Abidjan (Côte d’Ivoire)

Mamert Fulgence Yao Bathaix^*, Akelesso Bagny, Kouamé Alassane Mahassadi, Anassé Jean-Baptiste Okon, Ya Henriette Kissi-Anzouan, Stanislas Doffou, Aboubacar Demba Bangoura, Hatrydt Dimitri Kouamé, Kadiatou Diallo, Antonin N’Dam, Aoudi Ousman De, Koffi Alain Attia, Aya Thérèse N’dri Yoman

Department of Hepatology and Gastroenterology of the Centre Hospitalier Universitaire de Yopougon (CHU-Y), Abidjan, Cote d’Ivoire.

DOI: 10.4236/ojgas.2015.57017                

Abstract

Cirrhosis is the cause of a high rate of death in hospitals. The aim of this research was to estimate the incidence of mortality and identify the risk factors associated with cirrhosis patients in hospital in Cote d’Ivoire. Methodology: It is a retrospective study covering from January 1st, 2002 to December 31st, 2011 at Centre Hospitalier et Universitaire de Yopougon in Abidjan. We concerned the cirrhosis patients that have been followed at the hepatology and gastroenterology department. Survival was estimated by the Kaplan-Meier curve and comparison of survival curves by the log-rank test. The multi-varied analysis of the survivals has been achieved with the Cox proportional Hazard regression. A p value < 0.05 was taken as significant. Results: We recruited, 221 patients (135 men) of whom the medium age was 59 ± 15.12 years. Among those patients, 34.5% were classified as Child Pugh C and 52.94% Child Pugh B, 19.45% suffered from digestive hemorrhage, 26.5% suffered from renal deficiency, 47% suffered from hepatic encephalopathy and 10.7% from hyponatremia. The median overall survival of patients was 0.50 person-months. The variables that were significantly associated to a reduction of survival were hepatic encephalopathy (p = 0.0029), spontaneous ascitesfluid infection (p = 0.0208), hyponatremia (p = 0.0434) and stage Cof Child- Pugh score (p = 0.046). Conclusion: The incidence of mortality in cirrhotic patients hospitalized in Abidjan is high. Pejorative prognostic factors were essentially hepatic encephalopathy, spontaneous ascites fluid infection, hyponatremia and stage C of Child-Pugh score.

Keywords

Cirrhosis, Portal Hypertension, Child-Pugh, Encephalopathy, Prognostic, Côte d’Ivoire

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Friedman, S.L. (2003) Liver Fibrosis—From Bench to Bedside. Journal of Hepatology, 38, S38-S53. http://dx.doi.org/10.1016/S0168-8278(02)00429-4
[2]	Sawadogo, A., Diba, N., and Calès, P. (2007) Physiopathologie de la cirrhose et de ses complications. Réanimation, 16, 557-562. http://dx.doi.org/10.1016/j.reaurg.2007.09.001
[3]	Sehonou, J., Kodjoh, N., Sake, K. and Mouala, C. (2010) Cirrhose hépatique à Cotonou (République du Bénin): Aspects cliniques et facteurs liés au décès. Médecine Tropicale, 70, 375-378.
[4]	Attia, K.A., N’dri Yoman, A.T., Talla, P., Bathaix, Y., Mahassadi, A., Kissi, H., Brou, I., Touré, A. and Diomandé, I. (2003) Facteurs prédictifs des signes endoscopiques d’hypertension portale sévère chez le cirrhotique en milieu Africain: A propos de 131 cas. Médecine d’ Afrique Noire, 50, 109-114.
[5]	Anderson, R.N. (2002) Deaths. Leading Causes for 2000. National Vital Statistics Reports, 50.
[6]	Attia, K.A., Ackoundou, K.C., N’dri, A.T., et al. (2008) Child-Pugh-Turcott versus MELD Score for Predicting Survival in a Retrospective Cohort of Black African Cirrhotic Patients. World Journal of Gastroenterology, 14, 286-291. http://dx.doi.org/10.3748/wjg.14.286
[7]	Robert, R. and Veinstein, A. (2003) Pronostic du malade atteint de cirrhose en réanimation. Gastroentérologie Clinique et Biologique, 27, 877-881.
[8]	Bustamante, J., Rimola, A., Ventura, P.J., Nassava, M., Cirera, I., Reggiardo, V. and Rhodes, J. (1999) Prognostic Significance of Hepatic Encephalopathy in Patients with Cirrhosis. Journal of Pathology, 30, 890-895. http://dx.doi.org/10.1016/s0168-8278(99)80144-5
[9]	Runyon, B.A. (2013) American Association for the Study of Liver Diseases Introduction to the Revised American Association for the Study of Liver Diseases Practice Guideline Management of Adult Patients with Ascites Due to Cirrhosis 2012. Hepatology, 57, 1651-1653. http://dx.doi.org/10.1002/hep.26359
[10]	Ginès, P., Cardenas, A., Arroyo, V. and Rodes, J. (2004) Management of Cirrhosis and Ascites. NEJM, 350, 1646- 1654. http://dx.doi.org/10.1056/NEJMra035021
[11]	Singhal, S., Baikati, K.K., Jabbour, I.I. and Anand, S. (2012) Management of Refractory Ascites. American Journal of Therapeutics, 19, 121-132. http://dx.doi.org/10.1097/MJT.0b013e3181ff7a8b
[12]	de Guibert, B. (2012) Caractéristiques des patients présentant une hyponatrémie sévère en service de médecine: Epidé-miologie, clinique, étiologies et évolution. Human Health and Pathology, HAL ID: dumas-00769783.
[13]	Grangé, J.D. and Amiot, X. (1992) La prophylaxie des complications infectieuses par décontamination bactérienne digestive sélective chez les malades atteints de cirrhose. Gastroentérologie Clinique et Biologique, 16, 692-700.
[14]	Chagneau, C. (2004) Traitement et prévention de l’infection du liquide d’ascite. Gastroentérologie Clinique et Biolo- gique, 28, 138-145. http://dx.doi.org/10.1016/S0399-8320(04)95249-9
[15]	Gines, P., Rimola, A., Flessing, R., Vargas, V., Marco, F., Almela, M., et al. (1990) Norfloxacin Prevents Spontaneous Bacterial Peritonitis Recurrence in Cirrhosis: Result of a Double-Blind, Placebo-Controled Trial. Hepatology, 12, 716- 724. http://dx.doi.org/10.1002/hep.1840120416
[16]	Fernández-Esparrach, G., Sanchez-Fucip, A., Gines, P., Uriz, J., Quintó, L., Ventura, P.-J., et al. (2001) A Prognostic Model for Predicting Survival in Cirrhosis with Ascites. Journal of Hepatology, 34, 46-52. http://dx.doi.org/10.1016/S0168-8278(00)00011-8
[17]	Sandhu, B.S., Gupta, R., Sharma, J., Singh, J., Murthy, N.S. and Sarin, S.K. (2005) Norfloxacin and Cisapride Combination Decreases the Incidence of Spontaneous Bacterial Peritonitis in Cirrhotic Ascites. Journal of Gastroenterology and Hepatology, 20, 599-605. http://dx.doi.org/10.1111/j.1440-1746.2005.03796.x
[18]	Attia, K.A., N’driYoman, T., Sawadogo, A., Mahassadi, A., Bathaix-Yao, F., Sermé, K. and Kassi, L.M. (2001) L’infection spontanée du liquide d’ascite chez le cirrhotique africain. Etude descriptive à propos de 12 cas. Bulletin de la Société de Pathologie Exotique, 94, 319-321.
[19]	Perri, G.-A. (2013) L’ascite chez les patients atteints de cirrhose. Canadian Family Physician, 59, e538-e540.
[20]	Taoufik, R. (2011) Profil épidémiologique de l’hypertension portale au chu hassan II de fes. Thèse N 014/11, P.2.
[21]	Attia, K.A., N’driYoman, A.T., Mahassadi, A.K., Ackoundou-Nguessan, K.C., Kissi, H.Y. and Bathaix, Y.F. (2008) Impact of Renal Failure on Survival of African Patients with Cirrhosis. Saudi Journal of Kidney Diseases and Transplantation, 19, 587-592.
[22]	Ouakaa-Kchaou, A., Belhadj, N., Abdelli, N., Azzouz, M., Mami, N.B., Dougui, M.H., et al. (2010) Survie chez Le cirrhotique Tunisien. La Tunisie Medicale, 88, 804-808.
[23]	Follo, A., Liovet, J.M., Navara, M., Planas, R., Forns, X., Francitorra, A., et al. (1994) Renal Impairment after Spontaneous Bacterial Peritonitis in Cirrhosis: Incidence, Clinical Course, Predictive Factors and Prognosis. Hepatology, 20, 1495-1501.
[24]	Gex, L., Bernard, C. and Spahr, L. (2010) Scores en hépatologie: Child-Pugh, MELD et Maddrey. Revue Médicale Suisse, 1803-1808.
[25]	Castera, L., Pauwels, A. and Lévy, V. (1996) Indicateurs pronostiques chez les malades atteints de cirrhose admis en service de réanimation. Gastroentérologie Clinique et Biologique, 20, 263-268.
[26]	Bustamante, J., Rimola, A., Ventura, P.J., Navasa, M. and Cirera, V. (1999) Prognostic Significance of Hepatic Encephalopathy in Patients with Cirrhosis. Journal of Hepatology, 30, 890-895. http://dx.doi.org/10.1016/S0168-8278(99)80144-5
[27]	Benhaddouch, Z., Abidi, K., Naoufel, M., Abouqal, R. and Zeggwagh, A.A. (2007) Mortalité et facteurs pronostiques des patients cirrhotiques en encéphalopathie hépatique admis en réanimation. Annales Francaises d’Anesthésie et de Réanimation, 26, 490-495. http://dx.doi.org/10.1016/j.annfar.2007.04.005
[28]	Oberti, F. (1998) Pronostic de l’hypertension portale: Hemorragie digestive par rupture de varices oesophagiennes. Hépato-Gastro & Oncologie Digestive, 5, 371-377.
[29]	K.A. Mahassadi, Ndri Yoman, T., Kissi, Y.H., Bathaix-Yao, M.F., Doffou, S., Toualy, W. and Attia, K.A. (2007) Evaluation de la qualité de la prise en charge de l’hémorragie digestive liée à l’hypertension portale dans un pays en développement: Exemple du CHU de Yopougon (Abidjan-C0te d’Ivoire). Revue Internationale des Sciences Médicales d’Abidjan, 9, 35-42.
[30]	Botta, F., Giannini, E., Romagnoli, P., Fasoli, A., Malfatti, B. and Testa, R. (2003) MELD Scoring System Is Useful for Predicting Prognosis in Patients with Liver Cirrhosis and Is Correlated with Residual Liver Function: A European Study. Gut, 52, 134-139. http://dx.doi.org/10.1136/gut.52.1.134